Publications by authors named "M Jl DeJongste"
Objective: Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after single-port thoracoscopic sympathicotomy (SPTS).
Methods: Eight patients (six males, two females, median age of 45 years) with treatment-resistant RP underwent left-sided SPTS at the third rib (R3), unilaterally. Questionnaires were taken, and number and duration of RP attacks were reported over a 2-week period.
Background: Primary Focal Hyperhidrosis (PFH) has a detrimental effect on Quality of Life. Repetitive, non-curative symptomatic strategies dominate current treatment of PFH, in spite of the availability of an effective and permanent curative treatment like Endoscopic Thoracic Sympathectomy (ETS). Current surgical optimization may allow for a re-established position of sympathetic modulation in this treatment algorithm.
View Article and Find Full Text PDFArticle Synopsis
- - This study examines the effectiveness of a surgical procedure called bilateral, one-stage, single-port sympathicotomy (BOSS) for treating excessive sweating (palmar and axillary hyperhidrosis) in children up to 16 years old.
- - Out of 14 children who underwent the procedure, 50% experienced a return of sweating, and 35.7% needed additional surgery, which sometimes complicated the procedure.
- - Despite the high rates of recurrence and the need for repeat surgeries, patient satisfaction was relatively high, with a median score of 7.5 out of 9.
Introduction: The rising prevalence of modifiable risk factors (eg, obesity, hypertension and physical inactivity) is causing an increase in possible avoidable complications in patients undergoing cardiac surgery. This study aims to assess whether a combined preoperative and postoperative multidisciplinary cardiac rehabilitation (CR) programme (Heart-ROCQ programme) can improve functional status and reduce surgical complications, readmissions and major adverse cardiac events (MACE) as compared with standard care.
Methods And Analysis: Patients (n=350) are randomised to the Heart-ROCQ programme or standard care.